Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
42,194,093
-
Total 13F shares
-
13,199,169
-
Share change
-
+136,031
-
Total reported value
-
$222,025,113
-
Price per share
-
$16.82
-
Number of holders
-
49
-
Value change
-
+$2,268,000
-
Number of buys
-
17
-
Number of sells
-
18
Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS) as of Q1 2022
As of 31 Mar 2022,
Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,199,169 shares.
The largest 10 holders included
Vivo Capital, LLC, RTW INVESTMENTS, LP, Frazier Life Sciences Management, L.P., Cormorant Asset Management, LP, PERCEPTIVE ADVISORS LLC, TimesSquare Capital Management, LLC, COWEN AND COMPANY, LLC, VANGUARD GROUP INC, BlackRock Inc., and Jefferies Group LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.